Global Market Presence Inmunotek's products are available in Spain and over 50 other countries, indicating a well-established international distribution network that can be leveraged to expand sales channels and enter new markets.

Innovative Product Development The company's focus on developing novel therapies such as the bacterial vaccine Uromune presents opportunities to collaborate with healthcare providers seeking cutting-edge allergy and immunity treatments.

Recognition and Growth Being recognized as one of Europe’s Long-Term Growth Champions reflects a strong reputation and sustained growth potential, making Inmunotek an attractive partner for collaborations and sales expansion.

Regulatory Certifications Operating GMP-certified manufacturing centers in Spain ensures high-quality production standards, facilitating entry into regulated markets and building trust with healthcare professionals worldwide.

Award-Winning Innovation Receiving the National Innovation Award positions Inmunotek as a leader in healthcare innovation, providing an opportunity to promote unique, award-winning products to health systems and potential clients.